In Silico Analysis of Cell Cycle Synchronisation Effects in Radiotherapy of Tumour Spheroids

PLoS Computational Biology

Volumn 9, Issue 11, 2013, Pages

  Kempf, Harald ^a,b   Hatzikirou, Haralampos ^a,c   Bleicher, Marcus ^b   Meyer Hermann, Michael ^a,d  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b FRANKFURT INSTITUTE FOR ADVANCED STUDIES   (Germany)

^c CENTER FOR ADVANCING ELECTRONICS DRESDEN CFAED   (Germany)

^d TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMOUS AGENTS; CELLS; COMPUTATIONAL METHODS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DRUG DOSAGE; GROWTH KINETICS; TARGETED DRUG DELIVERY;

CELL CYCLE; CELL CYCLE PHASE; CELL-CYCLE PROGRESSION; CURRENT CELLS; EXTERNAL STIMULUS; IN-SILICO; RESYNCHRONIZATION; SILICO ANALYSIS; TUMOR SPHEROID; TUMOUR CELLS;

TUMORS;

ARTICLE; CANCER RADIOTHERAPY; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE RESYNCHRONISATION; COMPUTER MODEL; CONTROLLED STUDY; DNA DAMAGE; G1 PHASE CELL CYCLE CHECKPOINT; IRRADIATION; KINETICS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; SPHEROID CELL; TUMOR GROWTH; TUMOR SPHEROID; TUMOR VOLUME;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; MICE; MODELS, BIOLOGICAL; RADIOTHERAPY; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84888239900     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003295     Document Type: Article

References (92)

1. Withers HR, (1985) Biologic basis for altered fractionation schemes. Cancer 55: 2086-95.
2. Sinclair WK, (1968) Cyclic x-ray responses in mammalian cells in vitro. Radiation research 33: 620-43.
3. Elkind MM, Sutton-Gilbert H, Moses WB, Alescio T, Swain RW, (1965) Radiation Response of Mammalian Cells Grown in Culture. V. Temperature Dependence of the Repair of X-Ray Damage in Surviving Cells (Aerobic and Hypoxic). Radiation research 25: 359-76.
4. Geldof Aa, Plaizier MaBD, Duivenvoorden I, Ringelberg M, Versteegh RT, et al. (2003) Cell cycle perturbations and radiosensitization effects in a human prostate cancer cell line. Journal of cancer research and clinical oncology 129: 175-82.
5. Mac Manus MP, Hicks RJ, (2012) The role of positron emission tomography/computed tomography in radiation therapy planning for patients with lung cancer. Seminars in nuclear medicine 42: 308-19.
6. Kauppinen Ra, Peet AC, (2011) Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches. Cancer biology & therapy 12: 665-79.
7. Connell PP, Hellman S, (2009) Advances in radiotherapy and implications for the next century: a historical perspective. Cancer research 69: 383-92.
8. Carlin S, Humm JL, (2012) PET of hypoxia: current and future perspectives. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 53: 1171-4.
9. Parodi K, Bortfeld T, Enghardt W, Fiedler F, Knopf A, et al. (2008) PET imaging for treatment verification of ion therapy: Implementation and experience at GSI Darmstadt and MGH Boston. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 591: 282-286.
10. Brahme A, Lind BK, (2010) A systems biology approach to radiation therapy optimization. Radiation and environmental biophysics 49: 111-24.
11. Gao X, McDonald JT, Hlatky L, Enderling H, (2013) Acute and fractionated irradiation diferentially modulate glioma stem cell division kinetics. Cancer research 73: 1481-90.
12. Jain HV, Meyer-Hermann M, (2011) The molecular basis of synergism between carboplatin and ABT-737 therapy targeting ovarian carcinomas. Cancer research 71: 705-15.
13. Rejniak Ka, Anderson ARa, (2011) Hybrid models of tumor growth. Wiley interdisciplinary reviews Systems biology and medicine 3: 115-25.
14. Deisboeck TS, Wang Z, Macklin P, Cristini V, (2011) Multiscale cancer modeling. Annual review of biomedical engineering 13: 127-55.
15. Altinok A, Lévi F, Goldbeter A, (2007) A cell cycle automaton model for probing circadian patterns of anticancer drug delivery. Advanced drug delivery reviews 59: 1036-53.
16. Lévi F, (2001) Circadian chronotherapy for human cancers. The lancet oncology 2: 307.
17. Lévi F, Okyar A, Dulong S, Innominato PF, Clairambault J, (2010) Circadian timing in cancer treatments. Annual review of pharmacology and toxicology 50: 377-421.
18. Ballesta A, Dulong S, Abbara C, Cohen B, Okyar A, et al. (2011) A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery. PLoS computational biology 7: e1002143.
19. Billy F, Clairambault J, Fercoq O (2013) Optimisation of Cancer Drug Treatments Using Cell Population Dynamics. In: Ledzewicz U, Schättler H, Friedman A, Kashdan E, editors, Mathematical Methods and Models in Biomedicine, New York: Springer. pp. 265-309.
20. Mazzoccoli G, Sothern RB, Parrella P, Muscarella La, Fazio VM, et al. (2012) Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls. Clinical and experimental medicine 12: 181-94.
21. Sewlall S, Pillay V, Danckwerts MP, Choonara YE, Ndesendo VMK, et al. (2010) A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Current drug delivery 7: 370-88.
22. De Giorgi A, Mallozzi Menegatti A, Fabbian F, Portaluppi F, Manfredini R, (2013) Circadian rhythms and medical diseases: Does it matter when drugs are taken? European journal of internal medicine [epub ahead of print] doi: 10.1016/j.ejim.2013.03.019.
23. Kang TH, Sancar A, (2009) Circadian regulation of DNA excision repair: implications for chronochemotherapy. Cell cycle (Georgetown, Tex) 8: 1665-7.
24. Hahnfeldt P, Hlatky L, (1996) Resensitization due to redistribution of cells in the phases of the cell cycle during arbitrary radiation protocols. Radiation research 145: 134-43.
25. Kempf H, Bleicher M, Meyer-Hermann M, (2010) Spatio-temporal cell dynamics in tumour spheroid irradiation. The European Physical Journal D 60: 177-193.
26. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, et al. (2010) Multicellular tumor spheroids: an underestimated tool is catching up again. Journal of biotechnology 148: 3-15.
27. Beyer T, Schaller G, Deutsch A, Meyer-Hermann M, (2005) Parallel dynamic and kinetic regular triangulation in three dimensions. Computer Physics Communications 172: 86-108.
28. Schaller G, Meyer-Hermann M, (2005) Multicellular tumor spheroid in an off-lattice Voronoi- Delaunay cell model. Physical review E, Statistical, nonlinear, and soft matter physics 71: 051910.
29. Pampaloni F, Reynaud EG, Stelzer EHK, (2007) The third dimension bridges the gap between cell culture and live tissue. Nature reviews Molecular cell biology 8: 839-45.
30. Santini MT, Rainaldi G, Indovina PL, (2000) Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Critical reviews in oncology/hematology 36: 75-87.
31. Stuschke M, Budach V, Stüben G, Streffer C, Sack H, (1995) Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system. International journal of radiation oncology, biology, physics 32: 395-408.
32. Olive PL, Durand RE, (1994) Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer metastasis reviews 13: 121-38.
33. Topsch J, Scholz M, Mueller-Klieser W, (2007) Radiobiological characterization of human tumor cell multilayers after conventional and particle irradiation. Radiation research 167: 645-54.
34. Lin Yf, Nagasawa H, Peng Y, Chuang EY, Bedford JS, (2009) Comparison of several radiation effects in human MCF10A mammary epithelial cells cultured as 2D monolayers or 3D acinar stuctures in matrigel. Radiation research 171: 708-15.
35. Puliafito A, Hufnagel L, Neveu P, Streichan S, Sigal A, et al. (2012) Collective and single cell behavior in epithelial contact inhibition. Proceedings of the National Academy of Sciences of the United States of America 109: 739-44.
36. Mellor HR, Ferguson DJP, Callaghan R, (2005) A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs. British journal of cancer 93: 302-9.
37. Primeau AJ, Rendon A, Hedley D, Lilge L, Tannock IF, (2005) The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors. Clinical cancer research: an official journal of the American Association for Cancer Research 11: 8782-8.
38. Wilson GD, (2007) Cell kinetics. Clinical oncology (Royal College of Radiologists (Great Britain)) 19: 370-84.
39. Chu YS, Dufour S, Thiery JP, Perez E, Pincet F, (2005) Johnson-Kendall-Roberts theory applied to living cells. Physical review letters 94: 28102.
40. Festjens N, Vanden Berghe T, Vandenabeele P, (2006) Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochimica et biophysica acta 1757: 1371-87.
41. McClatchey AI, Yap AS, (2012) Contact inhibition (of proliferation) redux. Current opinion in cell biology 24: 685-94.
42. Tung YC, Hsiao AY, Allen SG, Torisawa Ys, Ho M, et al. (2011) High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. The Analyst 136: 473-8.
43. Freyer JP, Sutherland RM, (1986) Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply. Cancer research 46: 3504-12.
44. Wehrle JP, Ng CE, McGovern KA, Aiken NR, Shungu DC, et al. (2000) Metabolism of alternative substrates and the bioenergetic status of EMT6 tumor cell spheroids. NMR in biomedicine 13: 349-60.
45. Walenta S, Doetsch J, Mueller-Klieser W, Kunz-Schughart La, (2000) Metabolic Imaging in Multicellular Spheroids of Oncogene-transfected Fibroblasts. Journal of Histochemistry & Cytochemistry 48: 509-522.
46. Hall EJ, Giaccia AJ (2005) Radiobiology For The Radiologist. Lippincott Williams & Wilkins, 6th edition, 656 pp.
47. Masunaga S, Ono K, Abe M, (1991) A method for the selective measurement of the radiosensitivity of quiescent cells in solid tumors-combination of immunouorescence staining to BrdU and micronucleus assay. Radiation research 125: 243-7.
48. Steel GG (2002) Basic clinical radiobiology. London: CRC Press, 280 pp.
49. Masunaga SI, Ando K, Uzawa A, Hirayama R, Furusawa Y, et al. (2008) Responses of total and quiescent cell populations in solid tumors to carbon ion beam irradiation (290 MeV/u) in vivo. Radiation medicine 26: 270-7.
50. Hillen T, de Vries G, Gong J, Finlay C, (2010) From cell population models to tumor control probability: including cell cycle effects. Acta oncologica (Stockholm, Sweden) 49: 1315-23.
51. Saraste a, Pulkki K, (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovascular research 45: 528-37.
52. Dunne aL, Price ME, Mothersill C, McKeown SR, Robson T, et al. (2003) Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells. British journal of cancer 89: 2277-83.
53. Yanagihara K, Nii M, Numoto M, Kamiya K, Tauchi H, et al. (1995) Radiation-induced apoptotic cell death in human gastric epithelial tumour cells; correlation between mitotic death and apoptosis. International journal of radiation biology 67: 677-85.
54. Erenpreisa J, Cragg MS, (2001) Mitotic death: a mechanism of survival? A review. Cancer cell international 1: 1.
55. Hickman JA, (1992) Apoptosis induced by anticancer drugs. Cancer metastasis reviews 11: 121-39.
56. Eriksson D, Stigbrand T, (2010) Radiation-induced cell death mechanisms. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 31: 363-72.
57. Bohl J (2006) Charakterisierung von zwei Glioblastomzelllinien zur Vorbereitung für die Tumortherapie mit schweren Ionen in Kombination mit Chemotherapie. Diplomarbeit, TU Darmstadt. URL www-alt.gsi.de/forschung/bio/publics_files/thesis/dipl_thesis_bohl_2007.pdf.
58. Sham E, Durand RE, (1998) Cell kinetics and repopulation mechanisms during multifraction irradiation of spheroids. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 46: 201-7.
59. Hamada N, Imaoka T, Masunaga Si, Ogata T, Okayasu R, et al. (2010) Recent advances in the biology of heavy-ion cancer therapy. Journal of radiation research 51: 365-83.
60. Theron T, Slabbert J, Serafin A, Böhm L, (1997) The merits of cell kinetic parameters for the assessment of intrinsic cellular radiosensitivity to photon and high linear energy transfer neutron irradiation. International journal of radiation oncology, biology, physics 37: 423-8.
61. Masunaga Si, Ono K, Mitsumori M, Abe M, (1993) Alteration of Radiosensitivity of Quiescent Cell Populations in Solid Tumors Irradiated with X-Rays Twice at Various Intervals. Cancer Science 84: 1130-1135.
62. Barendsen GW, Van Bree C, Franken NA, (2001) Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments (review). International journal of oncology 19: 247-56.
63. Sham E, Durand RE, (1999) Repopulation characteristics and cell kinetic parameters resulting from multi-fraction irradiation of xenograft tumors in SCID mice. International journal of radiation oncology, biology, physics 43: 617-22.
64. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer Sa, et al. (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. International journal of radiation oncology, biology, physics 48: 7-16.
65. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, et al. (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368: 843-54.
66. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L, (2007) Stereotactic body radiation therapy in multiple organ sites. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 25: 947-52.
67. Kavanagh BD, Timmerman R, Meyer JL, (2011) The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy. Frontiers of radiation therapy and oncology 43: 370-81.
68. Hercbergs A, Davis PJ, Davis FB, Ciesielski MJ, Leith JT, (2009) Radiosensitization of GL261 glioma cells by tetraiodothyroacetic acid (tetrac). Cell cycle 8: 2586-91.
69. Ohri N, Dicker AP, Lawrence YR, (2012) Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data. International journal of radiation oncology, biology, physics 83: 385-93.
70. Sinclair WK, (1968) The combined effect of hydroxyurea and x-rays on Chinese hamster cells in vitro. Cancer research 28: 198-206.
71. Pawlik TM, Keyomarsi K, (2004) Role of cell cycle in mediating sensitivity to radiotherapy. International journal of radiation oncology, biology, physics 59: 928-42.
72. Durante M, Loeffler JS, (2010) Charged particles in radiation oncology. Nature reviews Clinical oncology 7: 37-43.
73. Bert C, Engenhart-Cabillic R, Durante M, (2012) Particle therapy for noncancer diseases. Medical physics 39: 1716-27.
74. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, et al. (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101: 1623-31.
75. Guerrero M, Li XA, (2004) Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Physics in medicine and biology 49: 4825-35.
76. Park C, Papiez L, Zhang S, Story M, Timmerman RD, (2008) Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. International journal of radiation oncology, biology, physics 70: 847-52.
77. Kirkpatrick JP, Meyer JJ, Marks LB, (2008) The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Seminars in radiation oncology 18: 240-3.
78. Brahme A, (2011) Accurate description of the cell survival and biological effect at low and high doses and LET's. Journal of radiation research 52: 389-407.
79. Shibamoto Y, Otsuka S, Iwata H, Sugie C, Ogino H, et al. (2012) Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model. Journal of radiation research 53: 1-9.
80. Williams JR, Zhang Y, Zhou H, Gridley DS, Koch CJ, et al. (2008) A quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 status. International journal of radiation biology 84: 253-64.
81. Biade S, Stobbe CC, Chapman JD, (1997) The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles. Radiation research 147: 416-21.
82. Wilson GD, (2004) Radiation and the cell cycle, revisited. Cancer metastasis reviews 23: 209-25.
83. Mendonca MS, Rodriguez A, Alpen EL, (1989) Quiescence in 9L cells and correlation with radiosensitivity and PLD repair. Radiation research 117: 433-47.
84. Lin A, Hahn SM, (2012) Hypoxia imaging markers and applications for radiation treatment planning. Seminars in nuclear medicine 42: 343-52.
85. Yasui H, Matsumoto S, Devasahayam N, Munasinghe JP, Choudhuri R, et al. (2010) Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice. Cancer research 70: 6427-36.
86. Freyer JP, Sutherland RM, (1985) A reduction in the in situ rates of oxygen and glucose consumption of cells in EMT6/Ro spheroids during growth. J Cell Physiol 124: 516-524.
87. Zacharaki EI, Stamatakos GS, Nikita KS, Uzunoglu NK, (2004) Simulating growth dynamics and radiation response of avascular tumour spheroids-model validation in the case of an EMT6/Ro multicellular spheroid. Computer methods and programs in biomedicine 76: 193-206.
88. Helmlinger G, Netti PA, Lichtenbeld HC, Melder RJ, Jain RK, (1997) Solid stress inhibits the growth of multicellular tumor spheroids. Nature biotechnology 15: 778-83.
89. Stein WD (1990) Channels, carriers, and pumps: An introduction to membrane transport. San Diego: Academic Press, 326 pp.
90. Casciari JJ, Sotirchos SV, Sutherland RM, (1988) Glucose Diffusivity in Multicellular Tumor Spheroids. Cancer Research 48: 3905-3909.
91. Grote J, Süsskind R, Vaupel P, (1977) Oxygen diffusivity in tumor tissue (DS-carcinosarcoma) under temperature conditions within the range of 20-40 degrees C. Pflügers Archiv: European journal of physiology 372: 37-42.
92. Qvarnström OF, Simonsson M, Eriksson V, Turesson I, Carlsson J, (2009) gammaH2AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT474 cellular spheroids. International journal of oncology 35: 41-7.